KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

National Health Investors (NHI) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for National Health Investors (NHI) over the last 14 years, with Q3 2025 value amounting to $32.8 million.

  • National Health Investors' Net Income towards Common Stockholders rose 1508.54% to $32.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $147.1 million, marking a year-over-year increase of 1610.12%. This contributed to the annual value of $137.9 million for FY2024, which is 167.41% up from last year.
  • National Health Investors' Net Income towards Common Stockholders amounted to $32.8 million in Q3 2025, which was up 1508.54% from $36.9 million recorded in Q2 2025.
  • In the past 5 years, National Health Investors' Net Income towards Common Stockholders registered a high of $43.2 million during Q4 2024, and its lowest value of $1.9 million during Q4 2022.
  • Its 4-year average for Net Income towards Common Stockholders is $31.1 million, with a median of $33.5 million in 2025.
  • Data for National Health Investors' Net Income towards Common Stockholders shows a peak YoY increase of 161910.9% (in 2023) and a maximum YoY decrease of 1491.53% (in 2023) over the last 5 years.
  • Over the past 4 years, National Health Investors' Net Income towards Common Stockholders (Quarter) stood at $1.9 million in 2022, then skyrocketed by 1619.11% to $32.0 million in 2023, then surged by 34.93% to $43.2 million in 2024, then dropped by 24.07% to $32.8 million in 2025.
  • Its Net Income towards Common Stockholders stands at $32.8 million for Q3 2025, versus $36.9 million for Q2 2025 and $34.1 million for Q1 2025.